Im interested to see in the next 4c a nice increase on ebita, they stated in their last quarter how they stocked up on software licenses to gain great discounts, so i expect a reduction in that cost.
Also would be nice to see staff cost stagnant as well. See if the appointment of a synergies manager (has to justify his own salary) has identified overlaps within the organisation and redeploy them to help with growth or unfortunately made redundant. Sad wish i have, but just realistic.
If we attack both ends of maintaining/reducing costs while growing the revenue that is when investors will see the scalability of the company.